United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Charles River, Related Sciences team up for AI-driven drug discovery Charles River Laboratories International, Inc. (NYSE: CRL) and Related Sciences have announced a multi-program collaboration valued at an… byPallavi MadhirajuSeptember 14, 2023